Champions Oncology, Inc. Financial Ratios — CSBR Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025	04/30/2026

Return on Common Equity (%)	-597.31	-119.92	-136.23	-233.48	-251.8	-2,157.99	-732.51	11.42	-57.05	5.78	6.63	-77.7	- -	- -	-30.48
Return on Assets (%)	-88.5	-68.16	-72.19	-125.66	-117.21	-99.85	-18.35	1.32	-13.07	1.5	1.74	-15.31	-24.08	16.08	-3.96
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	13.01	- -	2.34	3.21	- -	- -	- -	- -
Gross Margin (%)	31.47	35.98	45.77	13.88	22.32	37.04	47.86	47.3	47.08	47.74	51.88	45.18	41.38	50.15	48
EBITDA Margin (%)	-125.33	-72.31	-52.35	-146.95	-90.86	-43.09	-4.91	3.24	-2.37	3.78	4.55	-4.09	-10.08	11.39	0.59
Operating Margin (%)	-126.8	-74.74	-54.2	-149.36	-92.26	-44.18	-6.69	1	-4.94	0.89	1.24	-8.26	-13.8	8.51	-1.73
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	23.79	- -	21.89	2.99	- -	- -	173.32	- -
Pretax Margin (%)	-121.18	-75.93	-63.97	-146.82	-92.6	-44.55	-7.13	0.85	-6.11	1.06	1.19	-9.78	-14.57	8.12	-1.56
Profit Margin (%)	-121.15	-76.05	-64.12	-148.26	-93.42	-44.67	-7.29	0.47	-6.52	0.88	1.12	-9.9	-14.51	8.26	-1.98
Net Income to Common Margin (%)	-121.15	-76.05	-64.12	-148.26	-93.42	-44.67	-7.29	0.47	-6.52	0.88	1.12	-9.9	-14.51	8.26	-1.98
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	44.59	- -	17.16	6	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-597.31	-119.92	-136.23	-233.48	-251.8	-2,157.99	-732.51	11.42	-57.05	5.78	6.63	-77.7	- -	- -	-30.48

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025	04/30/2026

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	4	10	9	9	7	6	5
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	1	1	2
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	3	9	8	7	6	5	3
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	-0.04	0.02	-4.99	6.19	4.24	-3.9	-1.47	0.94	12.97
Net Debt/EBITDA	0.53	1.59	0.97	0.72	0.25	0.5	0.86	-3.7	10.96	-3.02	-4.03	4.59	0.52	-1.51	-14
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	-0.03	0.06	-2.39	26.23	15.59	-1.93	-1.07	1.26	-4.38
Net Debt/EBIT	0.52	1.54	0.94	0.71	0.25	0.48	0.63	-11.99	5.26	-12.81	-14.84	2.27	0.38	-2.02	4.73
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	41.62	65.88	36.06	66.9	4.12	4.99	0.04	19.87	24.57	26.92	25.71	13.51	-7.28	11.66	14.59
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	566.67	- -	62.17	118.24	92.48	159.43	- -	122.85	73.55
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	36.96	- -	35.63	51.58	45.32	55.84	110.24	46.92	34.87
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	0.21	- -	15.28	31.83	23.78	21.54	23.32	14.33	11.09
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	1,433.33	0.71	74.49	129.25	104.07	185.48	-390.44	161.85	110.91
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	93.48	0.71	42.69	56.38	51	64.97	134.43	61.81	52.59
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	0.53	0.14	18.3	34.8	26.76	25.06	28.43	18.88	16.72
Net Debt to Equity	-165.01	-124.56	-184.27	-116.11	-1,086.13	-823.75	-28,533.33	-144.64	-163.6	-63.1	-99.02	-218.25	137.57	-259.41	-119.76
Net Debt/Capital (%)	253.82	507.21	218.67	720.88	110.14	113.82	105.68	329.3	-1,503.06	-37.98	-94.26	-324.61	-90	-10,635.87	-131.39
EBITDA	-9	-6	-6	-13	-10	-7	-1	1	-1	2	2	-2	-5	6	- -
EBITDA-CapEx	-9	-6	-6	-13	-10	-7	-2	- -	-3	-2	- -	-5	-6	6	- -
Operating Income (Loss)	-9	-6	-6	-13	-10	-7	-1	- -	-2	- -	1	-4	-7	5	-1

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025	04/30/2026

Cash Ratio	1.36	3.26	1.61	2.46	0.49	0.44	0.11	0.4	0.68	0.42	0.52	0.47	0.12	0.41	0.24
Current Ratio	1.59	3.54	2.08	2.84	0.82	0.79	0.68	0.99	1.1	1.13	1.13	0.9	0.63	0.94	0.96
Quick Ratio	1.53	3.43	1.97	2.74	0.73	0.75	0.64	0.95	1.07	1.04	1.06	0.83	0.56	0.88	0.91
CFO/Avg Current Liab	-1.5	-1.34	-1.04	-2.58	-1.41	-0.45	-0.16	0.24	0.29	-0.14	0.45	0.2	-0.28	0.33	-0.2
Common Equity/Total Assets	41.62	65.88	36.06	66.9	4.12	4.99	0.04	19.87	24.57	26.92	25.71	13.51	-7.28	11.66	14.59
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	566.67	- -	62.17	118.24	92.48	159.43	- -	122.85	73.55
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	36.96	- -	35.63	51.58	45.32	55.84	110.24	46.92	34.87
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	0.21	- -	15.28	31.83	23.78	21.54	23.32	14.33	11.09
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	1,433.33	0.71	74.49	129.25	104.07	185.48	-390.44	161.85	110.91
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	93.48	0.71	42.69	56.38	51	64.97	134.43	61.81	52.59
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	0.53	0.14	18.3	34.8	26.76	25.06	28.43	18.88	16.72
CFO/Total Liabilities	-129.35	-108.23	-60.55	-241.47	-115.69	-37.31	-15.18	20.63	18.56	-8.34	24.72	13.39	-21.89	25.85	-19.51
CFO/CapEx	-10.07	-75.47	-14.67	-80.92	-19.9	-3.71	-1	2.23	1.31	-0.51	2.73	1.38	-7.34	18.99	-7.93
Altman's Z-Score	-5.44	-1.62	-0.73	0.86	-18.19	-12.15	-8.1	0.3	0.16	2.17	1.03	-0.77	-2.49	0.8	-0.02

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025	04/30/2026

Accounts Receivable Turnover	13.25	20.47	30.31	20.4	19.4	10.27	9.85	14.17	13.86	11.79	9.5	10.9	11.49	9.72	8.78
Days Sales Outstanding	27.54	17.83	12.04	17.89	18.82	35.54	37.07	25.75	26.34	30.95	38.43	33.47	31.76	37.56	41.59
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	3.01	3.7	5.73	6.37	5.25	5.18	5.27	5.75	5.72	8.52	9.93	7.2	5.28	5.65	5.54
Accounts Payable Turnover Days	121.29	98.65	63.67	57.26	69.55	70.49	69.28	63.47	63.84	42.84	36.77	50.69	69.11	64.59	65.86
Cash Conversion Cycle	-93.75	-80.82	-51.63	-39.37	-50.73	-34.96	-32.21	-37.72	-37.5	-11.89	1.65	-17.21	-37.35	-27.03	-24.27
Inventory to Cash Days	27.54	17.83	12.04	17.89	18.82	35.54	37.07	25.75	26.34	30.95	38.43	33.47	31.76	37.56	41.59
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025	04/30/2026

Market Capitalization	23	18	61	64	34	29	48	106	98	144	104	67	66	99	83
- Cash & Cash Equivalents	5	10	6	9	3	3	1	3	8	5	9	10	3	10	5
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	4	10	9	9	7	6	5
Enterprise Value	18	8	55	54	31	26	47	102	94	149	104	65	71	95	83
Total Capital	3	8	3	8	- -	- -	- -	2	9	17	19	13	6	10	9
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	93.48	0.71	42.69	56.38	51	64.97	134.43	61.81	52.59
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.04	0.06	0.09	0.13	0.11	0.06	0.05
EV/Sales	2.57	0.99	4.76	6.13	2.77	1.67	2.32	3.78	2.92	3.63	2.12	1.21	1.41	1.67	1.39
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	116.76	- -	96.03	46.69	- -	- -	14.62	237.17
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	378.83	- -	406.69	171.85	- -	- -	19.57	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	54.93	32.26	- -	16.06	16.39	- -	12.84	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	15,629.4	37.94	18.28	93.03	11.75	9.51	- -	12.2	- -
Diluted Market Cap	31	18	61	64	34	29	48	128	91	156	109	67	66	102	82
Diluted Enterprise Value	27	8	55	54	31	26	47	125	87	161	109	65	71	98	82
EV per Share	6.39	2.78	9.86	6.24	3.55	2.35	4.26	8.8	7.36	11.1	7.71	4.81	5.2	6.88	5.94
TTM Sales	7	8	12	9	11	15	20	27	32	41	49	54	50	57	59
TTM EBITDA	-9	-6	-6	-13	-10	-7	-1	1	-1	2	2	-2	-5	6	- -
TTM Operating Income	-9	-6	-6	-13	-10	-7	-1	- -	-2	- -	1	-4	-7	5	-1
TTM Cash Flow to Firm	-5	-4	-3	-10	-6	-3	-1	2	3	-2	6	4	-6	7	-4
TTM Free Cash Flow to Firm	-5	-4	-3	-10	-6	-2	- -	3	5	2	9	7	-5	8	-4

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	2026 Y
As of date	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025	04/30/2026

Price/Free Cash Flow	-6.66	-4.2	-19.03	-6.7	-5.51	-14.03	15,900.4	47.48	17.84	97.73	12.24	9.73	-12.39	13.12	-21.1
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	378.83	- -	406.69	171.85	- -	- -	19.57	- -
Enterprise Value	18	8	55	54	31	26	47	102	94	149	104	65	71	95	83
Low Price	7.44	2.52	5.16	2.4	3.22	1.11	2.28	3.92	4.02	7.05	7.06	3.75	4.17	3.6	5.5
EV/Sales	2.57	0.99	4.76	6.13	2.77	1.67	2.32	3.78	2.92	3.63	2.12	1.21	1.41	1.67	1.39
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	116.76	- -	96.03	46.69	- -	- -	14.62	237.17
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	804.44	- -	389.45	184.95	- -	- -	20.78	- -
Price/Earnings Average	-4.29	-2.6	-9.91	-5.51	-4.22	-4.12	-24.8	811.22	-39.55	368.03	220.04	-16.42	-10.69	18.55	-77.91
Price/Earnings High	-6.49	-3.83	-17.97	-8.34	-7.5	-7.64	-35.41	1,585.85	-59.08	532.82	270.93	-25.08	-13.63	34.84	-113.37
Price/Earnings Low	-3.35	-1.18	-3.88	-1.59	-2.68	-1.77	-17	347.29	-22.75	255.88	170.02	-9.52	-7.76	10.46	-64.75
Price/Book Value	8.03	2.32	19.04	7.9	140.81	72.76	15,900.4	47.14	19.27	19.38	11.42	14.37	-34.65	26.12	21.01
Price/Book Value Average	9.51	2.14	22.95	8.99	185.25	70.83	12,200.23	47.54	17.45	18.31	13.58	18.9	-41.01	23.31	23.33
Price/Book Value High	14.38	3.16	41.63	13.61	329.17	131.51	17,421.78	92.94	26.06	26.51	16.72	28.86	-52.29	43.79	33.95
Price/Book Value Low	7.43	0.98	9	2.59	117.77	30.48	8,362.45	20.35	10.03	12.73	10.5	10.96	-29.79	13.15	19.39
Price/Tangible Book Value	10.46	2.54	24.08	8.62	-77.76	-108.19	-71.62	67.24	20.62	20.29	11.85	15.49	-29.46	28.66	22.96
Price/Tangible Book Value Average	12.39	2.35	29.03	9.8	-102.3	-105.32	-54.96	67.81	18.67	19.18	14.1	20.38	-34.87	25.58	25.5
Price/Tangible Book Value High	18.73	3.46	52.65	14.84	-181.77	-195.56	-78.48	132.56	27.89	27.76	17.36	31.11	-44.46	48.06	37.11
Price/Tangible Book Value Low	9.68	1.07	11.38	2.83	-65.03	-45.32	-37.67	29.03	10.74	13.33	10.9	11.81	-25.33	14.43	21.19
Price/Sales	4.39	2.14	5.27	7.19	3	1.89	2.36	3.8	2.85	3.44	2.06	1.24	1.31	1.72	1.39
Price/Sales Average	5.2	1.98	6.35	8.17	3.94	1.84	1.81	3.84	2.58	3.25	2.46	1.63	1.55	1.53	1.54
Price/Sales High	7.86	2.91	11.52	12.37	7.01	3.41	2.58	7.5	3.85	4.7	3.02	2.48	1.98	2.88	2.24
Price/Sales Low	4.06	0.9	2.49	2.36	2.51	0.79	1.24	1.64	1.48	2.26	1.9	0.94	1.13	0.86	1.28
Price/Cash Flow	-6	-4.14	-17.73	-6.61	-5.23	-10.25	-38.91	55.3	31.47	-83.87	15.6	16.77	-10.71	13.22	-18.43
Price/Cash Flow Average	-7.11	-3.82	-21.37	-7.52	-6.88	-9.98	-29.85	55.77	28.5	-79.25	18.56	22.06	-12.67	11.8	-20.47
Price/Cash Flow High	-10.75	-5.63	-38.77	-11.39	-12.23	-18.52	-42.63	109.02	42.56	-114.74	22.85	33.68	-16.16	22.17	-29.79
Price/Cash Flow Low	-5.55	-1.74	-8.38	-2.17	-4.37	-4.29	-20.46	23.87	16.39	-55.1	14.34	12.78	-9.21	6.66	-17.01
Price/Free Cash Flow Average	-7.89	-3.87	-22.94	-7.61	-7.24	-13.66	12,200.23	47.87	16.15	92.36	14.57	12.8	-14.67	11.71	-23.43
Price/Free Cash Flow High	-11.93	-5.71	-41.61	-11.53	-12.87	-25.36	17,421.78	93.59	24.13	133.71	17.94	19.55	-18.71	22	-34.09
Price/Free Cash Flow Low	-6.17	-1.76	-8.99	-2.2	-4.61	-5.88	8,362.45	20.5	9.29	64.21	11.26	7.42	-10.66	6.61	-19.47
EV/Sales Average	3.17	0.83	5.84	7.11	3.71	1.62	1.77	3.81	2.63	3.43	2.53	1.6	1.65	1.48	1.54
EV/Sales High	5.13	1.76	11.01	11.32	6.78	3.2	2.54	7.57	3.99	4.92	3.11	2.46	2.08	2.84	2.25
EV/Sales Low	2.33	- -	1.98	1.3	2.28	0.58	1.2	1.56	1.45	2.42	1.95	0.91	1.23	0.81	1.28
EV/EBITDA Average	-2.53	-1.14	-11.16	-4.84	-4.09	-3.77	-36	117.78	-110.93	90.92	55.51	-39.09	-16.39	12.99	263.44
EV/EBITDA High	-4.09	-2.44	-21.04	-7.7	-7.46	-7.43	-51.76	233.75	-168.62	130.21	68.3	-60.05	-20.64	24.9	383.62
EV/EBITDA Low	-1.86	0.34	-3.78	-0.89	-2.5	-1.34	-24.42	48.32	-61.26	64.18	42.94	-22.37	-12.17	7.08	218.81
EV/EBIT Average	-2.5	-1.11	-10.78	-4.76	-4.02	-3.68	-26.43	382.12	-53.23	385.05	204.31	-19.36	-11.97	17.39	-89.1
EV/EBIT High	-4.05	-2.36	-20.32	-7.58	-7.34	-7.24	-38	758.4	-80.91	551.45	251.38	-29.74	-15.07	33.33	-129.74
EV/EBIT Low	-1.84	0.33	-3.65	-0.87	-2.47	-1.31	-17.93	156.77	-29.39	271.81	158.04	-11.07	-8.89	9.48	-74
Last Price	8.04	6	10.92	7.32	3.85	2.65	4.34	9.08	7.72	10.73	7.68	4.92	4.85	7.15	5.96
High Price	14.4	8.16	23.88	12.6	9	4.79	4.75	17.9	10.44	14.68	11.25	9.88	7.32	11.99	9.63
Enterprise Value Average	23	7	67	63	42	25	36	103	84	141	124	86	83	84	92
Enterprise Value High	37	15	127	100	76	49	51	205	128	202	153	132	104	162	133
Enterprise Value Low	17	-2	23	12	25	9	24	42	47	99	96	49	61	46	76

Shares Outstanding	3	3	6	9	9	11	11	12	13	13	14	14	14	14	14
Diluted Weighted Avg Shares	4	3	6	9	9	11	11	14	12	15	14	14	14	14	14
Basic Weighted Avg Shares	4	3	6	9	9	11	11	11	12	13	13	14	14	14	14
Revenue per Share	1.83	2.8	2.07	1.02	1.28	1.4	1.84	2.39	2.71	3.12	3.72	3.98	3.7	4.17	4.3
EBITDA per Share	-2.3	-2.03	-1.08	-1.5	-1.17	-0.6	-0.09	0.08	-0.06	0.12	0.17	-0.16	-0.37	0.47	0.03
Operating Income per Share	-2.32	-2.09	-1.12	-1.52	-1.19	-0.62	-0.12	0.02	-0.13	0.03	0.05	-0.33	-0.51	0.35	-0.07
Basic EPS, GAAP	-2.22	-2.13	-1.33	-1.51	-1.2	-0.63	-0.13	0.01	-0.18	0.03	0.04	-0.39	-0.54	0.34	-0.08
Basic EPS from Cont Ops	-2.22	-2.13	-1.33	-1.51	-1.2	-0.63	-0.13	0.01	-0.18	0.03	0.04	-0.39	-0.54	0.34	-0.08
Diluted EPS, GAAP	-2.22	-2.13	-1.33	-1.51	-1.2	-0.63	-0.13	0.01	-0.18	0.02	0.04	-0.39	-0.54	0.33	-0.08
Diluted EPS from Cont Ops	-2.22	-2.13	-1.33	-1.51	-1.2	-0.63	-0.13	0.01	-0.18	0.02	0.04	-0.39	-0.54	0.33	-0.08
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.34	-1.45	-0.62	-1.11	-0.74	-0.26	-0.11	0.16	0.25	-0.13	0.49	0.29	-0.45	0.54	-0.32
Free Cash Flow per Basic Share	-1.47	-1.47	-0.66	-1.12	-0.77	-0.33	-0.22	0.09	0.06	-0.38	0.31	0.08	-0.51	0.51	-0.36
Cash & Equivalents per Share	1.65	3.22	1.06	1.08	0.3	0.3	0.08	0.28	0.66	0.35	0.67	0.75	0.19	0.71	0.35
Book Value per Share	1	2.58	0.57	0.93	0.03	0.04	- -	0.19	0.4	0.55	0.67	0.34	-0.14	0.27	0.28
Tangible Book Value per Share	0.77	2.36	0.45	0.85	-0.05	-0.02	-0.06	0.14	0.37	0.53	0.65	0.32	-0.16	0.25	0.26

Champions Oncology, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)